Literature DB >> 15358951

Diagnosis of moyamoya disease with transcranial Doppler sonography: correlation study with magnetic resonance angiography.

Yong-Seok Lee1, Keun-Hwa Jung, Jae-Kyu Roh.   

Abstract

BACKGROUND AND
PURPOSE: Although the diagnosis of moyamoya disease may be confirmed by digital subtraction angiography, recent studies have shown the accuracy of magnetic resonance angiography. Characteristics of transcranial Doppler, a noninvasive and cost-effective method, and specific transcranial Doppler parameters reflecting distinct vascular status in moyamoya disease are explored. METHOD AND PATIENTS: Consecutive patients (> 15 years of age) diagnosed with moyamoya disease by a typical clinical history and digital sub traction angiography or magnetic resonance angiography were included. The statuses of the anterior, middle, and posterior cerebral arteries were graded as stage 1, stage 2, and stage 3 by magnetic resonance angiography. Mean flow velocity and pulsatility index were compared between these groups, and the receiver operating characteristic analysis was used to define transcranial Doppler criteria for distinct vascular status.
RESULTS: Forty-five patients were included (37 women; mean age, 34.9 +/- 11.4 years). Mean flow velocity was higher and pulsatility index was lower in stage 2 (P < .01), while mean flow velocity was lower and pulsatility index was higher in stage 3 than in stage 1 (P < .01). Cutoff values reflecting stenosis or occlusion with substantial sensitivity and specificity were as follows: mean flow velocity > 85 cm/s or pulsatility index < 0.60 for stage 2, and mean flow velocity < 50 cm/s for stage 3 of middle cerebral artery; mean flow velocity > 80 cm/s or pulsatility index < 0.60 for stage 2 of anterior cerebral artery; and mean flow velocity > 60 cm/s or pulsatility index < 0.60 for stage 2 of posterior cerebral artery.
CONCLUSION: Transcranial Doppler may help to refine magnetic resonance angiography findings and thus help clinicians differentiate severity or stages of moyamoya disease.

Entities:  

Mesh:

Year:  2004        PMID: 15358951     DOI: 10.1177/1051228404264958

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  10 in total

Review 1.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

2.  Hemodynamic contribution of transdural collateral flow in adult patients with moyamoya disease.

Authors:  Ji Man Hong; Yoon Hee Hong; Seong-Joon Lee; Sung Eun Lee; Jin Soo Lee; Dong Hoon Shin
Journal:  Neurol Sci       Date:  2016-09-02       Impact factor: 3.307

Review 3.  Transcranial Doppler in children.

Authors:  Suzanne Verlhac
Journal:  Pediatr Radiol       Date:  2011-04-27

4.  Recurrent transient ischemic attacks in a moyamoya syndrome patient with ultra-long imaging follow-up.

Authors:  Lan Zhang; Wei Xing; Jiajia Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-03

5.  Moyamoya disease: Diagnostic imaging.

Authors:  Eugeniusz Tarasów; Alina Kułakowska; Adam Lukasiewicz; Katarzyna Kapica-Topczewska; Alicja Korneluk-Sadzyńska; Joanna Brzozowska; Wiesław Drozdowski
Journal:  Pol J Radiol       Date:  2011-01

6.  Intracranial hemodynamic changes during adult moyamoya disease progression.

Authors:  Hyun-Jeong Kwag; Dong-Wook Jeong; Suk Hoon Lee; Dae Hyun Kim; Jei Kim
Journal:  J Clin Neurol       Date:  2008-06-20       Impact factor: 3.077

Review 7.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

8.  Color Doppler ultrasonography as an alternative tool for postoperative evaluation of collaterals after indirect revascularization surgery in Moyamoya disease.

Authors:  Shin-Joe Yeh; Sung-Chun Tang; Li-Kai Tsai; Chung-Wei Lee; Ya-Fang Chen; Hon-Man Liu; Shih-Hung Yang; Meng-Fai Kuo; Jiann-Shing Jeng
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

9.  Prospective screening of family members with moyamoya disease patients.

Authors:  Cong Han; Hui Feng; Yi-Qin Han; Wei-Wei Liu; Zheng-Shan Zhang; Wei-Zhong Yang; Lian Duan
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

10.  Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.

Authors:  Sharon E Cox; Julie Makani; Deogratias Soka; Veline S L'Esperence; Edward Kija; Paula Dominguez-Salas; Charles R J Newton; Anthony A Birch; Andrew M Prentice; Fenella J Kirkham
Journal:  Br J Haematol       Date:  2014-02-21       Impact factor: 6.998

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.